The Best AI Show on Pharma
In a world where healthcare decisions are getting faster, smarter, and more complex, one force is quietly reshaping the entire pharma landscape: intelligence. Not the kind you read in reports, but the kind that emerges when data, science, and experience collide. The Best AI Show on Pharma steps right into that intersection. Hosted by Ayush Mishra, this podcast brings you candid, future-facing conversations with leaders who are redefining how medicines are discovered, developed, and delivered.
Each episode goes beyond buzzwords, beyond hype, and beyond surface-level talk. These are the real stories, the challenges no one admits, the breakthroughs no one sees coming, and the visions shaping the next decade of medicine. Whether you are a pharma professional, a healthcare innovator, or someone who believes that smarter technology can lead to better outcomes, this is where the future becomes understandable, practical, and actionable.
The Best AI Show on Pharma
Ep #6 | From Google to Drug Discovery with AI: Why "Science Advances One Funeral at a Time" | Javier Tordable
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
Early-stage drug discovery can take years and requires deep expertise in computational chemistry that most biologists don't have. This creates a massive bottleneck in getting new therapies from concept to testing.
In this episode, Ayush Mishra sits down with Javier Tordable, Founder & CEO of Pauling.AI, to explore how AI is automating the most time-intensive parts of drug discovery and why adoption remains the industry's biggest challenge.
You will hear insights on:
- Why he left 16 years at Google to focus entirely on pharmaceutical AI
- How rational drug design works and where the traditional process breaks down
- What Pauling.AI does differently, an AI agent that handles target identification, molecular design, and binding predictions like ChatGPT handles text
- The real resistance AI faces from veteran scientists and the uncomfortable truth about generational change in pharma
- When we can expect to see the first fully AI-designed drugs receive FDA approval
- Where emerging market founders can find datasets when premium pharmaceutical data is locked behind paywalls
- What human scientists will always do better than AI, and why that matters
- His brutally honest take on the "science advances one funeral at a time" phenomenon
- Practical advice for biotech entrepreneurs building AI healthcare companies in Asia and Africa
If you work in pharma R&D, drug discovery, biotech innovation, computational chemistry, or clinical development strategy, this conversation offers an unfiltered view of where AI is actually taking pharmaceutical research.
Javier Tordable's LinkedIn: https://www.linkedin.com/in/jtordable/
Ayush Mishra's LinkedIn: https://www.linkedin.com/in/ayushmishra/
